Bone Mineral Density in Postmenopausal Women With Primary Breast Cancer Who Are Receiving Treatment on Clinical Trial
- Conditions
- Breast CancerOsteoporosis
- First Posted Date
- 2006-07-20
- Last Posted Date
- 2020-04-02
- Lead Sponsor
- NCIC Clinical Trials Group
- Target Recruit Count
- 497
- Registration Number
- NCT00354302
- Locations
- 🇨🇦
Cambridge Memorial Hospital, Cambridge, Ontario, Canada
🇨🇦Odette Cancer Centre, Toronto, Ontario, Canada
🇨🇦St. Michael's Hospital, Toronto, Ontario, Canada
BCG With or Without Gefitinib in Treating Patients With High-Risk Bladder Cancer
- Conditions
- Bladder Cancer
- Interventions
- First Posted Date
- 2006-07-14
- Last Posted Date
- 2023-08-04
- Lead Sponsor
- NCIC Clinical Trials Group
- Target Recruit Count
- 41
- Registration Number
- NCT00352079
- Locations
- 🇨🇦
Clinical Research Unit at Vancouver Coastal, Vancouver, British Columbia, Canada
🇨🇦CHUQ-Pavillon Hotel-Dieu de Quebec, Quebec City, Quebec, Canada
🇨🇦Centre hospitalier universitaire de Sherbrooke, Sherbrooke, Quebec, Canada
Radiation in Stage I or Stage II Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery
- Conditions
- Lung Cancer
- Interventions
- Radiation: 3-dimensional conformal radiation therapy
- First Posted Date
- 2006-06-29
- Last Posted Date
- 2023-08-04
- Lead Sponsor
- NCIC Clinical Trials Group
- Target Recruit Count
- 80
- Registration Number
- NCT00346320
- Locations
- 🇨🇦
Tom Baker Cancer Centre, Calgary, Alberta, Canada
🇨🇦BCCA - Fraser Valley Cancer Centre, Surrey, British Columbia, Canada
🇨🇦BCCA - Vancouver Island Cancer Centre, Victoria, British Columbia, Canada
AZD2171 and Standard Combination Chemotherapy in Advanced Non-Small Cell Lung Cancer or Colorectal Cancer
- Conditions
- Lung CancerColorectal Cancer
- First Posted Date
- 2006-06-23
- Last Posted Date
- 2023-08-04
- Lead Sponsor
- NCIC Clinical Trials Group
- Target Recruit Count
- 31
- Registration Number
- NCT00343408
- Locations
- 🇨🇦
Ottawa Hospital Regional Cancer Centre - General Campus, Ottawa, Ontario, Canada
🇨🇦Princess Margaret Hospital, Toronto, Ontario, Canada
🇨🇦Jewish General Hospital - Montreal, Montreal, Quebec, Canada
Lenalidomide and Melphalan in Treating Patients With Previously Untreated Multiple Myeloma
- Conditions
- Multiple Myeloma and Plasma Cell Neoplasm
- First Posted Date
- 2006-03-22
- Last Posted Date
- 2023-08-04
- Lead Sponsor
- NCIC Clinical Trials Group
- Target Recruit Count
- 51
- Registration Number
- NCT00305812
- Locations
- 🇨🇦
Allan Blair Cancer Centre at Pasqua Hospital, Regina, Saskatchewan, Canada
🇨🇦Nova Scotia Cancer Centre, Halifax, Nova Scotia, Canada
🇨🇦Hopital Notre-Dame du CHUM, Montreal, Quebec, Canada
AZD0530 and Gemcitabine in Locally Advanced/Metastatic Pancreatic Cancer That Cannot Be Removed By Surgery
- Conditions
- Pancreatic Cancer
- Interventions
- First Posted Date
- 2005-12-15
- Last Posted Date
- 2023-08-04
- Lead Sponsor
- NCIC Clinical Trials Group
- Target Recruit Count
- 34
- Registration Number
- NCT00265876
- Locations
- 🇨🇦
Univ. Health Network-Princess Margaret Hospital, Toronto, Ontario, Canada
🇨🇦Ottawa Health Research Institute - General Division, Ottawa, Ontario, Canada
🇨🇦Algoma District Cancer Program, Sault Ste. Marie, Ontario, Canada
Docetaxel and Prednisone With/Out OGX-011 in Recurrent or Metastatic Prostate Cancer That Did Not Respond to Previous Hormone Therapy
- Conditions
- Prostate Cancer
- Interventions
- First Posted Date
- 2005-11-24
- Last Posted Date
- 2023-08-04
- Lead Sponsor
- NCIC Clinical Trials Group
- Target Recruit Count
- 82
- Registration Number
- NCT00258388
- Locations
- 🇨🇦
London Regional Cancer Program, London, Canada
🇨🇦BCCA - Cancer Centre for the Southern Interior, Kelowna, Canada
🇺🇸University of Washington, Seattle, Washington, United States
OGX-011 and Docetaxel in Treating Women With Locally Advanced or Metastatic Breast Cancer
- Conditions
- Breast Cancer
- First Posted Date
- 2005-11-24
- Last Posted Date
- 2023-08-04
- Lead Sponsor
- NCIC Clinical Trials Group
- Target Recruit Count
- 15
- Registration Number
- NCT00258375
- Locations
- 🇨🇦
British Columbia Cancer Agency - Centre for the Southern Interior, Kelowna, British Columbia, Canada
🇨🇦British Columbia Cancer Agency - Vancouver Cancer Centre, Vancouver, British Columbia, Canada
🇨🇦BCCA - Fraser Valley Cancer Centre, Surrey, British Columbia, Canada
Everolimus in Treating Patients WIth Recurrent or Metastatic Breast Cancer
- First Posted Date
- 2005-11-21
- Last Posted Date
- 2023-08-04
- Lead Sponsor
- NCIC Clinical Trials Group
- Target Recruit Count
- 49
- Registration Number
- NCT00255788
- Locations
- 🇨🇦
Toronto Sunnybrook Regional Cancer Centre at Sunnybrook and Women's College Health Sciences Centre, Toronto, Ontario, Canada
🇨🇦Margaret and Charles Juravinski Cancer Centre, Hamilton, Ontario, Canada
🇨🇦British Columbia Cancer Agency - Vancouver Cancer Centre, Vancouver, British Columbia, Canada
Paclitaxel + Carboplatin With/Out Cediranib Maleate in Stage III or Stage IV Non-Small Cell Lung Cancer
- Conditions
- Lung Cancer
- Interventions
- First Posted Date
- 2005-10-27
- Last Posted Date
- 2023-08-04
- Lead Sponsor
- NCIC Clinical Trials Group
- Target Recruit Count
- 296
- Registration Number
- NCT00245154
- Locations
- 🇨🇦
University Institute of Cardiology and, Quebec, Canada
🇷🇴Oncological Institute "Ion Chiricuta", Cluj-Napoca, Romania
🇷🇴Clinical County Hospital of Sibiu, Sibiu, Romania